Insulinpumpen: Auf dem Weg zum künstlichen Pankreas

Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

Zur Anmeldung

AutorIn: OÄ Dr. Ingrid Schütz-Fuhrmann

3. Medizinische Abteilung für Endokrinologie, Stoffwechselerkrankungen und Nephrologie, Krankenhaus Hietzing, Wien


1 Pickup JC, Sutton AJ, Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta­analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008; 25:765–74
2 Carlsson BM et al., Insulin pump-long-term effects on glycemic control: an observational study at 10 diabetes clinics in Sweden. Diabetes Technol Ther 2013 Apr; 15(4):302–7. DOI: 10.1089/dia.2012.0286. Epub 2013 Mar 28
3 Heinmann L, J Diabetes Sci Technol Nov 2009; 3(6):1490–500
4 Pańkowska E et al., Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes. Pediatr Diabetes 2009; 10(5):298–303
5 Ramotowska A, Szypowska A, Bolus calculator and wirelessly communicated blood glucose measurement effectively reduce hypoglycaemia in type 1 diabetic children – randomized controlled trial. Diabetes Metab Res Rev 2014 Feb; 30(2):146–53. DOI: 10.1002/dmrr.2477.
6 Enander R et al., Carbohydrate counting with a bolus calculator improves post-prandial blood glucose levels in children and adolescents with type 1 diabetes using insulin pumps. R Pediatr Diabetes 2012 Nov; 13(7):545–51. DOI: 10.1111/j.1399-5448.2012.00883.x. Epub 2012 Jul 8
7 JDRF Study Group, The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009 Aug; 32(8):1378–83
8 Bergenstal RM et al., STAR 3 Study Group, Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. NEJM 2010 Jul 22; 363(4):311–20
9 Battelino T et al., SWITCH Study Group, The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 2012 Dec; 55(12):3155–62
10 Ly TT et al., Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013 Sep 25; 310(12):1240–7
11 Reznik Y et al., OpT2mise Study Group, Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet 2014 Oct 4; 384(9950):1265–72. DOI: 10.1016/S0140-6736(14)61037-0 [Epub 2014 Jul 2]
12 Klonoff DC et al., ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia. J Diabetes Sci Technol 2013 Jul 1; 7(4):1005–10
13 Phillip M et al., Nocturnal glucose control with an artificial pancreas at a diabetes camp. NEJM 2013 Feb 28; 368(9):824–33

UIM 09|2014

Herausgeber: o. Univ.-Prof. Dr. Günter J. Krejs, Österreichische Gesellschaft für Innere Medizin
Publikationsdatum: 2014-12-16